NCT04346134

Brief Summary

Several studies were conducted to compare extracorporeal shockwave lithotripsy (SWL) and percutaneous nephrolithotomy (PNL) as treatment options for medium size lower caliceal high dense stones. However, no studies compared these options for non- lower polar stones. In the present study the investigators will compare mini-PNL and SWL in treatment of non- lower polar, medium size, high dense renal stones in reference to the stone free rate and safety of the procedures. Pre-operative evaluation including abdominal non-contrasted computed tomography will be performed for all patients. Patients will be randomly allocated into two equal groups and will be treated by either mini-PNL or SWL. postoperative, patients will be followed by regularly for 3 months. the outcome of the procedures will be evaluated and compared between groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 15, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

July 14, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

February 7, 2022

Status Verified

February 1, 2022

Enrollment Period

5 months

First QC Date

April 13, 2020

Last Update Submit

February 4, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Stone Free Rate

    No residual renal stone or residual fragment(s) less than 4 mm size

    as detected by non-contrasted computed tomography 3 months after the intervention procedures.

Secondary Outcomes (1)

  • Complications

    Intra- and 3 months post-operative complications

Study Arms (2)

mini-PNL group

EXPERIMENTAL

In which percutaneous nephrolithotomy will be performed using miniature nephroscope.

Procedure: mini-PNL

SWL group

EXPERIMENTAL

In which extracorporeal shock wave lithotripsy will be performed using Dornier lithotripter SII

Procedure: SWL

Interventions

mini-PNLPROCEDURE

Percutaneous nephrolithotomy using miniature nephroscope. The procedure will be performed under general or spinal anesthesia under fluoroscopy guidance.

mini-PNL group
SWLPROCEDURE

Extracorporal shockwave lithotripsy using Dornier SII lithotripter. the procedure will be performed under sedoanalgesia, and fluoroscopy will be used for stone localization; for a maximum of 3 SWL session.

SWL group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with high density (\>1000 HU), non-lower polar, single renal stone of 10 to 20 mm size

You may not qualify if:

  • Pregnant women, morbid obesity, severe orthopaedic deformities, any co-morbidities precluding general anaesthesia or prone positioning, uncorrectable coagulation disorders, active urinary tract infection (UTI), stone in calyceal diverticulum, abnormal renal anatomy and urinary tract obstruction distal to the stone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urology Department, Al-Azhar University Hospital

Cairo, 11633, Egypt

Location

MeSH Terms

Conditions

Nephrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Double-arm, prospective, Randomized, intervention study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Urology and Andrology

Study Record Dates

First Submitted

April 13, 2020

First Posted

April 15, 2020

Study Start

July 14, 2020

Primary Completion

December 1, 2020

Study Completion

March 1, 2021

Last Updated

February 7, 2022

Record last verified: 2022-02

Locations